Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous dendritic cells (1 trial)
hla-g-car.bite allogeneic γδ t cells (1 trial)
umbilical cord mesenchymal stem cells (4 trials)
umsc01 (1 trial)
Glioblastoma (Phase 2)
Infarction (Phase 1)
Myocardial Infarction (Phase 1)
Stroke (Phase 1)
Trials (7 total)
Trial APIs (4 total)